Truncated Midkine as a Marker for Gastrointestinal Cancer
Author Information
Author(s): K Aridome, S Takao, T Kaname, K Kadomatsu, S Natsugoe, F Kijima, T Aikou, T Muramatsu
Primary Institution: Kagoshima University Faculty of Medicine
Hypothesis
Can truncated midkine mRNA serve as a marker for nodal metastases in gastrointestinal carcinomas?
Conclusion
Truncated midkine mRNA is expressed in various gastrointestinal cancers and could be a useful marker for detecting nodal metastases.
Supporting Evidence
- Truncated midkine mRNA was expressed in 30 of 46 primary gastrointestinal cancers examined.
- Truncated midkine was not detected in adjacent non-cancerous tissues.
- All 14 lymph node metastases from ten cancer patients expressed truncated midkine mRNA.
Takeaway
This study looked at cancer samples to see if a specific marker, called truncated midkine, could help find cancer spread in lymph nodes.
Methodology
The study used polymerase chain reaction (PCR) to analyze the expression of truncated midkine mRNA in 47 surgically removed gastrointestinal cancer specimens.
Limitations
The study had a small sample size and focused only on gastrointestinal cancers.
Participant Demographics
The mean age of participants was 61.5 years, with a male/female ratio of 1.9.
Want to read the original?
Access the complete publication on the publisher's website